» Articles » PMID: 28881620

EETs Reduces LPS-induced Hyperpermeability by Targeting GRP78 Mediated Src Activation and Subsequent Rho/ROCK Signaling Pathway

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Sep 9
PMID 28881620
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Integrity of endothelial barrier is a determinant of the prognosis in the acute lung injury caused by sepsis. The epoxyeicosatrienoic acids (EETs), metabolites of arachidonic acid, exhibit protective effects in various pathogenic states, however, whether EETs play a role in endothelial barrier enhancement and the involved mechanisms remain to be investigated. Here, we show that increased EETs level by endothelial specific cytochrome P450 epoxygenase 2J2 over-expression and soluble epoxide hydrolase (sEH) inhibitor TPPU reduced lipopolysaccharide-induced endothelial hyper-permeability , accompanied by improved survival of septic mice. In addition, sEH inhibitor AUDA and 11,12-EET also decreased endothelial hyper-permeability in the study. Importantly, the relative mechanisms were associated with reduced GRP78-Src interaction and ROS production, and subsequently reduced RhoA/ROCK activation, and eventually decreased VE-cadherin and myosin light chain (MLC) phosphorylation. Thus CYP2J2-EETs is crucial for RhoA-dependent regulation of cytoskeletal architecture leading to reversible changes in vascular permeability, which may contribute to the development of new therapeutic approaches for pulmonary edema and other diseases caused by abnormal vascular permeability.

Citing Articles

Selected Interleukins Relevant to Multiple Sclerosis: New Directions, Potential Targets and Therapeutic Perspectives.

Mado H, Stasiniewicz A, Adamczyk-Sowa M, Sowa P Int J Mol Sci. 2024; 25(20).

PMID: 39456713 PMC: 11506881. DOI: 10.3390/ijms252010931.


Inhibitors of soluble epoxide hydrolase on acute lung injury: a meta-analysis of preclinical studies.

Tao W, Xu G, Luo Y, Li P Inflammopharmacology. 2022; 30(6):2027-2033.

PMID: 36085400 DOI: 10.1007/s10787-022-01063-2.


A Novel Role for Cytochrome P450 Epoxygenase Metabolites in Septic Shock.

Jones T, Janani L, Gordon A, Al-Beidh F, Antcliffe D Crit Care Explor. 2022; 4(1):e0622.

PMID: 35083437 PMC: 8785925. DOI: 10.1097/CCE.0000000000000622.


Rho-Proteins and Downstream Pathways as Potential Targets in Sepsis and Septic Shock: What Have We Learned from Basic Research.

da Silveira Hahmeyer M, Da Silva-Santos J Cells. 2021; 10(8).

PMID: 34440613 PMC: 8391638. DOI: 10.3390/cells10081844.


Knockout of cytochrome P450 1A1 enhances lipopolysaccharide-induced acute lung injury in mice by targeting NF-κB activation.

Tian L, Tang X, Ma W, Wang J, Zhang W, Liu K FEBS Open Bio. 2020; 10(11):2316-2328.

PMID: 32935470 PMC: 7609787. DOI: 10.1002/2211-5463.12977.


References
1.
Theken K, Lee C . Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk. Pharmacogenomics. 2007; 8(10):1369-83. DOI: 10.2217/14622416.8.10.1369. View

2.
Paszti-Gere E, Barna R, Kovago C, Szauder I, Ujhelyi G, Jakab C . Changes in the distribution of type II transmembrane serine protease, TMPRSS2 and in paracellular permeability in IPEC-J2 cells exposed to oxidative stress. Inflammation. 2014; 38(2):775-83. DOI: 10.1007/s10753-014-9988-9. View

3.
Mong P, Wang Q . Activation of Rho kinase isoforms in lung endothelial cells during inflammation. J Immunol. 2009; 182(4):2385-94. DOI: 10.4049/jimmunol.0802811. View

4.
Gong P, Angelini D, Yang S, Xia G, Cross A, Mann D . TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia. J Biol Chem. 2008; 283(19):13437-49. PMC: 2442341. DOI: 10.1074/jbc.M707986200. View

5.
Wojciak-Stothard B, Ridley A . Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol. 2003; 39(4-5):187-99. DOI: 10.1016/s1537-1891(03)00008-9. View